Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study | Synapse
February 3, 2025Open Access
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Swedish Cancer Society, Confederation of Regional Cancer Centres, and Swedish governmental funding for clinical research.